Q3 2019 financial information and update on the partnership with Boehringer Ingelheim

NEXT STORY
Valneva Announces Appointments of Two Leading Vaccine Experts to its Scientific Advisory Board
PREV STORY
Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

aTyr Pharma Announces Co-Founder of the Foundation for Sarcoidosis Research and Leading Sarcoidosis Advocate Andrea Wilson as Patient Advisor

author_avatar
NASDAQ Market News

Myriad Receives Reimbursement for the BRACAnalysis® Diagnostic System in Japan for Patients with Breast or Ovarian Cancer Associated with HBOC

author_avatar
NASDAQ Market News

MediciNova Announces MN-001 (tipelukast) Abstract regarding Lipid Metabolism in NASH/NAFLD Accepted for Presentation at The Liver Meeting® 2021, the Annual Meeting of the American Association for the Study of Liver Diseases

author_avatar
NASDAQ Market News